Altamira Therapeutics Ltd. (CYTO) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Altamira Therapeutics Ltd...

    NASDAQ: CYTO · Real-Time Price · USD
    0.30
    0.00 (0.00%)
    At close: Jan 16, 2025, 10:00 PM

    Altamira Therapeutics Cash Flow Statement

    Financials in CHF. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -3.87M -26.53M -17.39M
    Depreciation & Amortization
    		 119.3K 118.89K 76.36K
    Stock-Based Compensation
    		 n/a 342.8K 1.21M
    Other Working Capital
    		 -3.92M 2.73M 1.35M
    Other Non-Cash Items
    		 -3.42M 13.83M 1.9M
    Deferred Income Tax
    		 -99.85K -10.33K 21.62K
    Change in Working Capital
    		 -4.24M 3.56M 511.11K
    Operating Cash Flow
    		 -11.51M -8.68M -13.67M
    Capital Expenditures
    		 n/a -2.14M -3.33M
    Cash Acquisitions
    		 1.43M n/a n/a
    Purchase of Investments
    		 n/a n/a -179.1K
    Sales Maturities Of Investments
    		 10.04K n/a n/a
    Other Investing Acitivies
    		 505.00 969.00 -179.1K
    Investing Cash Flow
    		 1.44M -2.14M -3.51M
    Debt Repayment
    		 1.05M 5.92M -68.7K
    Common Stock Repurchased
    		 n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a
    Other Financial Acitivies
    		 9.57M 3.91M 6.68M
    Financial Cash Flow
    		 10.62M 9.83M 6.61M
    Net Cash Flow
    		 602.01K -968.8K -10.27M
    Free Cash Flow
    		 -11.51M -10.83M -17M

    Add to Watchlist